BRD4 inhibitor treatment of IgE-mediated diseases
US11389433B2 · kind B2 · utility
0Cited by
6References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 18, 2019 |
| Grant date | Jul 19, 2022 |
| Priority date | — |
| Expiry date | Jun 18, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Certain embodiments are directed to methods of using BRD4 inhibitors for treating IgE-mediated diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.